Pharmacological correction of gating defects in the voltage-gated Ca(v)2.1 Ca²⁺ channel due to a familial hemiplegic migraine mutation.
Pharmacological correction of gating defects in the voltage-gated Ca(v)2.1 Ca²⁺ channel due to a familial hemiplegic migraine mutation.
复制标题
DOI:
10.1016/j.neuron.2013.10.056
复制
发表时间:
2014-01-08
期刊:
影响因子:
16.2
通讯作者:
Lee A
中科院分区:
文献类型:
--
作者:
Inagaki A;Frank CA;Usachev YM;Benveniste M;Lee A
Voltage-gated ion channels exhibit complex properties, which can be targeted in pharmacological therapies for disease. Here, we report that the pro-oxidant, tert-butyl dihydroquinone (BHQ), modulates Cav2.1 Ca2+ channels in ways that oppose defects in channel gating and synaptic transmission resulting from a familial hemiplegic migraine mutation (S218L). BHQ slows deactivation, inhibits voltage-dependent activation, and potentiates Ca2+- dependent facilitation of Cav2.1 channels in transfected HEK293T cells. These actions of BHQ help offset the gain-of-function and reduced Ca2+-dependent facilitation of Cav2.1 channels with the S218L mutation. Transgenic expression of the mutant channels at the Drosophila neuromuscular junction causes abnormally elevated evoked postsynaptic potentials and impaired synaptic plasticity, which are largely restored to the wild-type phenotypes by BHQ. Our results reveal a new mechanism by which a Cav2.1 gating modifier can ameliorate defects associated with a disease-causing mutation in Cav2.1.
登录
查看更多内容
DOI:
10.1073/pnas.2237000100
发表时间:
2003-12-23
影响因子:
11.1
作者:
Lee, A;Zhou, H;Catterall, WA
通讯作者:
Catterall, WA
影响因子:
3
作者:
Christel, Carl;Lee, Amy
通讯作者:
Lee, Amy
影响因子:
5.3
作者:
Kawasaki, F;Zou, BY;Ordway, RW
通讯作者:
Ordway, RW
影响因子:
5.5
作者:
Brody, DL;Patil, PG;Yue, DT
通讯作者:
Yue, DT
DOI:
10.1073/pnas.0511322103
发表时间:
2006-03-07
影响因子:
11.1
作者:
Erxleben, C;Liao, YH;Armstrong, DL
通讯作者:
Armstrong, DL